Nomura Asset Management
LEGN icon

Nomura Asset Management’s Legend Biotech LEGN Stock Holding History

Nomura Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Hold
11,100
– – ﹤0.01% 840
2026
Q1 		$201K Hold
11,100
– – ﹤0.01% 891
2025
Q4 		$241K Hold
11,100
– – ﹤0.01% 870
2025
Q3 		$362K Hold
11,100
– – ﹤0.01% 838
2025
Q2 		$394K Hold
11,100
– – ﹤0.01% 828
2025
Q1 		$377K Buy
11,100
+3,700
+50% +$133K ﹤0.01% 835
2024
Q4 		$241K Hold
7,400
– – ﹤0.01% 885
2024
Q3 		$361K Hold
7,400
– – ﹤0.01% 847
2024
Q2 		$328K Hold
7,400
– – ﹤0.01% 859
2024
Q1 		$415K Buy
7,400
+1,700
+30% +$103K ﹤0.01% 849
2023
Q4 		$343K Hold
5,700
– – ﹤0.01% 869
2023
Q3 		$383K Hold
5,700
– – ﹤0.01% 868
2023
Q2 		$393K Hold
5,700
– – ﹤0.01% 877
2023
Q1 		$275K Buy
5,700
+1,200
+27% +$58.7K ﹤0.01% 901
2022
Q4 		$225K Hold
4,500
– – ﹤0.01% 911
2022
Q3 		$184K Hold
4,500
– – ﹤0.01% 918
2022
Q2 		$248K Hold
4,500
– – ﹤0.01% 924
2022
Q1 		$164K Hold
4,500
– – ﹤0.01% 961
2021
Q4 		$210K Buy
+4,500
New +$228K ﹤0.01% 961

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nomura Asset Management's LEGN Position: Q2 2026 in Review

Nomura Asset Management held its Legend Biotech (LEGN) position steady in Q2 2026 at 11,100 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Nomura Asset Management first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $415K in Q1 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Nomura Asset Management held 11,100 shares of Legend Biotech worth $321K as of Q2 2026.
  • Nomura Asset Management left its Legend Biotech share count unchanged in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #840 holding.
  • Nomura Asset Management first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
  • Nomura Asset Management's Legend Biotech position peaked at $415K in Q1 2024.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.